NCT00103220View on ClinicalTrials.gov

SJG-136 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

SJG-136

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00103220 - SJG-136 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter